PT923730E - Rastreio pré-natal da síndrome de down utilizando gonadotrofina hiperglicosilada - Google Patents

Rastreio pré-natal da síndrome de down utilizando gonadotrofina hiperglicosilada Download PDF

Info

Publication number
PT923730E
PT923730E PT97943383T PT97943383T PT923730E PT 923730 E PT923730 E PT 923730E PT 97943383 T PT97943383 T PT 97943383T PT 97943383 T PT97943383 T PT 97943383T PT 923730 E PT923730 E PT 923730E
Authority
PT
Portugal
Prior art keywords
syndrome
prenatal screening
hyperglycosylated gonadotropin
hyperglycosylated
gonadotropin
Prior art date
Application number
PT97943383T
Other languages
English (en)
Inventor
Laurence A Cole
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of PT923730E publication Critical patent/PT923730E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/806—Fertility tests
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
PT97943383T 1996-09-06 1997-09-05 Rastreio pré-natal da síndrome de down utilizando gonadotrofina hiperglicosilada PT923730E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2556896P 1996-09-06 1996-09-06

Publications (1)

Publication Number Publication Date
PT923730E true PT923730E (pt) 2008-12-04

Family

ID=21826817

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97943383T PT923730E (pt) 1996-09-06 1997-09-05 Rastreio pré-natal da síndrome de down utilizando gonadotrofina hiperglicosilada

Country Status (10)

Country Link
US (1) US6429018B1 (pt)
EP (2) EP1992944A1 (pt)
JP (2) JP3950481B2 (pt)
AT (1) ATE412896T1 (pt)
CA (1) CA2264840C (pt)
DE (1) DE69739072D1 (pt)
DK (1) DK0923730T3 (pt)
ES (1) ES2317656T3 (pt)
PT (1) PT923730E (pt)
WO (1) WO1998010282A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500627B1 (en) * 1998-02-03 2002-12-31 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by HCG assay
US7198954B1 (en) * 1999-02-03 2007-04-03 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by hCG assay
US6927034B2 (en) 1998-02-03 2005-08-09 The Trustees Of Columbia University In The City Of New York Methods for detecting trophoblast malignancy by HCG assay
US6994966B2 (en) * 2000-02-17 2006-02-07 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
WO2000061638A2 (en) * 1999-04-12 2000-10-19 Trustees Of Columbia University In The City Of New York Detection of cancer and abnormal pregnancy using monoclonal antibodies specific for hcg isoforms
WO2003012445A1 (en) 2001-07-30 2003-02-13 Quest Diagnostics Investments Incorporated Methods and kits for detecting ita in a biological sample
US20030027234A1 (en) * 2001-07-30 2003-02-06 Pandian Murugan R. Methods for detecting Down's syndrome
US6627457B2 (en) * 2001-07-30 2003-09-30 Quest Diagnostics Investments Incorporated Methods for detecting pregnancy
US7314760B2 (en) * 2003-06-10 2008-01-01 Stc. Unm Biochemical test for identifying pregnancies with Down's syndrome fetus
GB2404734A (en) * 2003-08-05 2005-02-09 Secr Defence A method of screening a sample for abnormally glycosylated and/or expressed proteins
US7315787B2 (en) * 2003-10-07 2008-01-01 Ntd Laboratories, Inc. Multi-marker screening protocol for fetal abnormalities
AT500321B1 (de) * 2003-12-30 2006-02-15 Red Bull Gmbh Verfahren zur diagnose des down-syndroms
US20050148096A1 (en) * 2004-01-07 2005-07-07 Cole Laurence A. Methods for detecting pregnancy
US7572639B2 (en) * 2004-06-03 2009-08-11 Stc.Unm Method and apparatus for predicting pregnancy outcome
US7666683B1 (en) 2004-10-13 2010-02-23 Stc.Unm Rapid method of diagnosing a normal pregnancy with high accuracy
US20060105411A1 (en) * 2004-11-15 2006-05-18 Cole Laurence A Method of detecting early pregnancy at high accuracy by measuring hCG and hyperglycosylated hCG concentrations equally
US8642330B2 (en) * 2005-08-08 2014-02-04 Onconon, Llc Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
WO2009040133A1 (en) * 2007-09-26 2009-04-02 Universitätsklinikum Heidelberg Osteopontin as novel prognostic biomarker for heart failure
US8269163B2 (en) * 2008-05-03 2012-09-18 New York University Biomarkers of ionizing radiation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874693A (en) * 1986-10-10 1989-10-17 Mark Bogart Method for assessing placental dysfunction
US5506150A (en) * 1987-07-09 1996-04-09 3I Research Exploitation Limited Prenatal screening for down's syndrome
US5356817A (en) * 1988-06-09 1994-10-18 Yale University Methods for detecting the onset, progression and regression of gynecologic cancers
US5445968A (en) * 1989-01-03 1995-08-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Purification of human chorionic gonadotropin β-core molecule and preparation of antibodies with specificity for same
US5252489A (en) * 1989-01-17 1993-10-12 Macri James N Down syndrome screening method utilizing dried blood samples
JP3537535B2 (ja) 1994-07-14 2004-06-14 株式会社中埜酢店 免疫グロブリンｇ結合糖鎖構造に基づく臨床検査方法
US5674727A (en) * 1994-08-31 1997-10-07 Cole; Laurence A. Human chorionic gonadotropin beta-subunit nicking enzyme

Also Published As

Publication number Publication date
CA2264840A1 (en) 1998-03-12
CA2264840C (en) 2006-04-04
DK0923730T3 (da) 2009-02-09
JP3950481B2 (ja) 2007-08-01
EP0923730A4 (en) 1999-10-13
JP2007163505A (ja) 2007-06-28
JP2001506744A (ja) 2001-05-22
ES2317656T3 (es) 2009-04-16
EP0923730B1 (en) 2008-10-29
DE69739072D1 (de) 2008-12-11
WO1998010282A1 (en) 1998-03-12
EP0923730A1 (en) 1999-06-23
ATE412896T1 (de) 2008-11-15
EP1992944A1 (en) 2008-11-19
US6429018B1 (en) 2002-08-06

Similar Documents

Publication Publication Date Title
PT923730E (pt) Rastreio pré-natal da síndrome de down utilizando gonadotrofina hiperglicosilada
DE69931910D1 (en) Pränatales screening für downs-syndrom
ATE230488T1 (de) Screeningverfahren für das down-syndrom unter verwendung von getrockneten blutproben
AU6802698A (en) Non-invasive method for isolation and detection of foetal DNA
IT1270130B (it) Strumento diagnostico automatizzato in particolare per l'analisi di campioni in pacchi di prova per un analita
CA2121680A1 (en) Screening method for identifying women at increased risk for preterm delivery
EP0489588A3 (en) Atr objective and method for sample analysis
CA2141668A1 (en) Method and apparatus for detecting down syndrome by non-invasive maternal blood screening
CA2204305A1 (en) Apparatus and method for determination of urine color
ATE163971T1 (de) Verfahren zur isolierung von fetalen zytotrophoblastzellen
DE3882140D1 (en) Praenatales screening fuer downs-syndrom.
AU2848795A (en) Antenatal screening for pregnancy abnormalities
GB2236185B (en) Process,specimen and device for making an analyte available for an investigation
WO1999064860A3 (en) Predictive test for pre-eclampsia
AU1652597A (en) Prenatal screening of fetal abnormalities
ZA953586B (en) Method and apparatus for the analysis of glucose in a biological sample
CA2068660A1 (en) Non-invasive method for isolation and detection of fetal dna
UA9032A (uk) Спосіб прогнозування внутрішньочеревного розвитку опорно-рухового апарату плоду